For best results when printing this announcement, please click on link below:
http://pdf.reuters.com/htmlnews/htmlnews.asp?i=43059c3bf0e37541&u=urn:newsml:reuters.com:20170525:nGNE5myqqC
Albion Development VCT PLC Interim Management Statement
Introduction
I am pleased to present Albion Development VCT PLC (the "Company")'s interim
management statement for the period from 1 January 2017 to 31 March 2017.
Performance and dividends
The Company's unaudited net asset value (NAV) as at 31 March 2017 was £50.1
million or 74.0 pence per share (excluding treasury shares), an increase of
3.3 pence per share (4.7 per cent.) since 31 December 2016.
After accounting for the dividend of 2.0 pence per share to be paid on 31 May
2017 to shareholders on the register on 5 May 2017, the NAV is 72.0 pence per
share.
Share issues
During the period from 1 January 2017 to 31 March 2017, the Company issued new
Ordinary shares under the Albion VCTs Prospectus Top Up Offers 2016/2017:
Date Number of shares issued Issue price per share (including costs of issue) Net proceeds £'000
31 January 2017 5,374,871 70.4p to 71.1p 3,707
Share buybacks
During the period from 1 January 2017 to 31 March 2017, the Company purchased
84,000 Ordinary shares for £56,000 at an average price of 66.7p pence per
Ordinary share. All of the shares are to be held in treasury.
It is the Board's intention for such buy-backs to be at around a 5 per cent.
discount to net asset value, so far as market conditions and liquidity permit.
Portfolio
The following investments have been made during the period from 1 January 2017
to 31 March 2017:
New investments £000s Activity
Quantexa Limited 315 Predictive analytics platform to protect and detect complex financial crime
Beddlestead Farm Limited 10 Seed investment to develop and operate dedicated wedding venues in the UK
Total new investments 325
Further investments £000s Activity
Black Swan Data Limited 155 Data analysis that supports corporate decision making
Dysis Medical Limited 147 Medical devices for the detection of cervical cancer
Total further investments 302
Disposals
The following disposals and loan stock repayments were made during the period
from 1 January 2017 to 31 March 2017:
Portfolio company £000s
Masters Pharmaceuticals Limited 524 Disposal of investment
AMS Sciences Limited 169 Disposal of investment
Radnor House School (Holdings) Limited 88 Loan stock repayment
Alto Prodotto Wind Limited 12 Loan stock and redemption premium repayment
Total proceeds 793
Top ten holdings as at 31 March 2017:
Investment Value £000s % of net asset value Activity
Radnor House School (Holdings) Limited 5,348 10.7% Independent schools for children aged 5-18
Egress Software Technologies Limited 2,737 5.5% Encrypted email & file transfer service provider
Proveca Limited 2,323 4.6% Repositioning of paediatric medicines
Chonais River Hydro Limited 2,099 4.2% Hydropower project in Scotland
The Street by Street Solar Programme Limited 1,972 3.9% Owns and operates photovoltaic systems on domestic properties in the UK
Regenerco Renewable Energy Limited 1,683 3.4% Generator of renewable energy from roof top solar installations
Grapeshot Limited 1,553 3.1% Provider of digital marketing software
Alto Prodotto Wind Limited 1,286 2.6% Owns and operates community scale wind energy projects on brownfield sites in the UK
Earnside Energy Limited 1,284 2.6% An anaerobic digestion plant
Mirada Medical Limited 1,264 2.5% Developer of medical imaging software
A full breakdown of the Company's portfolio can be found on the Fund's webpage
on the Manager's website at www.albion-ventures.co.uk/funds/AADV, by following
the 'Portfolio of Investments' link under the 'Funds reports' section.
Material events and transactions after the period end
Share issues
After the period end, the Company issued the following new Ordinary shares
under the Albion VCTs Prospectus Top Up Offers 2016/2017:
Date Number of shares issued Issue price per share (including costs of issue) Net proceeds £'000
7 April 2017 247,632 72.2p to 72.9p 175
The Board announced on 30 January 2017 that the Company had reached its £4
million limit under its offer pursuant to the Prospectus dated 29 November
2016, and so was closed. The proceeds of the Offer are being used to provide
further resources to the Company at a time when a number of attractive new
investment opportunities are being seen.
Portfolio
After the period end, the Company had the following material investment
transactions:
* Disposal of Blackbay Limited for £1,154k of which £52k is deferred and
held in escrow;
* Investment of £1,000k in a new company, MPP Global Solutions Limited, which
offers a cloud billing platform for enterprise subscription businesses in the
media, sport and retail sectors;
* Investment of £138k in an existing investee company, Panaseer Limited,
which provides a cyber security service;
* Investment of £130k in an existing investee company, Grapeshot Limited,
which develops digital marketing software;
* Investment of £53k in an existing investee company, Mirada Medical Limited,
which develops medical imaging software.
Further information
The Company continues to offer a Dividend Reinvestment Scheme to existing
shareholders. Details of this Scheme can be found on the Fund's webpage on the
Manager's website at www.albion-ventures.co.uk/funds/AADV.
Further information regarding historic and current financial performance and
other useful shareholder information can be found on the Fund's webpage on the
Manager's website under www.albion-ventures.co.uk/funds/AADV.
Geoffrey Vero, Chairman
25 May 2017
For further information please contact:
Patrick Reeve, Albion Ventures LLP - Tel: 020 7601 1850
LEI Code 213800FDDMBD9QLHLB38
This announcement is distributed by Nasdaq Corporate Solutions on behalf of
Nasdaq Corporate Solutions clients.
The issuer of this announcement warrants that they are solely responsible for
the content, accuracy and originality of the information contained therein.
Source: Albion Development VCT PLC - Ordinary Shares via Globenewswire